The Global Adolescent and Young Adult Cancer Congress is now considering abstracts for the 5 th Congress to be held in Long Beach, California from June 20-23, 2023 at the Long Beach Convention and Entertainment Center. The theme of the 2023 conference is REAL WORLD AYA CANCER CARE: PROGRESS AND OPPORTUNITIES. Abstracts can be submitted in any of the following categories:

• Changing Epidemiology of AYA Cancer
• Disparities & Equity
• Mental Health/Psychosocial
• Global Policies
• Targeted Therapies
• Transitions of Care

Medical professionals and advocates in Adolescent and Young Adult (AYA) cancer care are encouraged to submit abstracts as part of a symposium or as individual podium or poster presentations. We welcome research, program/service delivery, clinical, and community partnerships, including meta- analyses, systematic reviews, case presentations, and program evaluations. Preferred abstracts will address the conference theme and objectives, focusing on research, practice, training, and advocacy endeavors that support diversity, equity, and inclusion in AYA cancer care as related to race, ethnicity, age, religion, culture, language, disability, socioeconomic status, sexual orientation, and gender identity and/or expression. We particularly encourage symposia that include community partners as discussants, as well as podium and poster presentation submissions from community partners.

COMMUNITY PARTNERS SUBMISSION QUALIFICATIONS

By “community partners,” we are referring broadly to individuals who work in the field of AYA oncology outside of traditional academic and clinical settings. Community partners include, but are not limited to, patient advocates, patient navigators, staff and leaders of community-based non-profit organizations, or lay people with lived experiences relevant to cancer. We encourage scientists and clinicians working with these community partners to include them in their symposia submissions. We also encourage community partners to submit abstracts about their work or narratives using the “Community Partner” submission category. 

POSTER AND ORAL ABSTRACTS ARE SUBMITTED UNDER THE SAME LINK. DURING THE SUBMISSION PROCESS, SELECT WHICH YOU WOULD LIKE TO BE CONSIDERED FOR:

• POSTER
• ORAL PRESENTATION
• BOTH

 SUBMISSION DEADLINES

• Breakout Session – CLOSED*
• Poster/Oral Sessions – March 20, 2023 

*Decisions on breakout sessions will be announced the week of March 13, 2023, allowing those not selected for a breakout session to resubmit their abstract as a poster/oral session. Poster/Oral Session decisions will be announced the last week of April.

Proposals should report original work relating to improving the lives and outcomes of adolescents / young adults living with or beyond cancer. The presenter should be involved in the original work.

ABSTRACT GUIDELINES/SUBMISSION INSTRUCTIONS

CLICK HERE to download a printable instruction sheet (PDF). Please read carefully before submitting.

SUBMISSION REQUIREMENTS FOR BREAKOUT SESSION AND ORAL PRESENTATIONS:

When submitting your abstract, you will be asked to identify your abstract as research (basic & applied, metaanalyses, systematic reviews), program/service delivery (program evaluations, policy implementation), clinical (case reports and clinical services) or community partner. Reference below for instructions and submission specifications for both breakout session and poster/oral. Incomplete submissions will not be considered.

To submit your proposal, please follow the instructions below:

• Visit the 2023 Abstract Submission Portal: https://ayaglobalcancercongress.joyncongress.com
• If you are a new submitter or your email address is not recognized by the system, please create a new account.
• Should you have any issues email [email protected] 

 POSTER & ORAL SUBMISSIONS

The information below should be submitted through the Global AYACC online submission portal by the posted deadline. Poster and Oral submissions are submitted under the same link. Excluding title, co-authors, and references word limit is 300.

• Title
• Poster/Oral Presentation Preference
• The following should be included for each individual presentation (excluding title and co-authors,
  300 word limit):
  • Introduction/Background
  • Aims/Objectives
  • Methodology
  • Results
  • Discussion/Conclusion
• Co-Authors (names and affiliations)
  • References
  • Keywords

Learning Objectives

• The submitter will be required to provide 2 learning objectives, using action verbs and listing measurable objectives. For example, “The participant shall be able to analyze the practice implications of…” instead of, “The participant shall be able to understand the practice implications of…”
• CV Upload & Financial Disclosure: All participants must upload a copy of their CV and a financial disclosure for accreditation purposes.

Abstracts will be assessed for acceptability against the criteria below:

1. Abstracts should relate to the authors’ own work.
2. It is a condition of acceptance that the presenting authors attends the congress as a registered delegate. Please note acceptance of abstracts does not include registration for Congress and this must be arranged separately.
3. The submitted abstract should relate to original work in AYA cancer and will report a completed piece of work or work in progress that will be completed in time to allow findings to be reported in the presentation.
4. The work presented should be original to the author(s) and ensure reliance can be placed on the accuracy of data /findings presented. The introduction should be used to put the presentation into the current context of AYA cancer care.
5. Fully completed online form.
6. The reviewing panel reserves the right to decline any submission not thought to meet the criteria or felt to be incompatible with the overall objectives of the Congress. Individual decisions will not be discussed.

Additional instructions pertaining to all submissions:

• Background/Purpose. Clearly state the purpose of the abstract, describing the focus and significance to the field of AYA oncology.
• Methods. For basic & applied research abstracts, describe the study’s design, participants, setting, data collection, and analytic approach. For meta-analysis & systematic review research abstracts, identify the databases searched, criteria for selection and inclusion of studies in the analysis, and methods for assessing risk of bias. For clinical case study abstracts, include the referral problem, assessment data and diagnosis, case conceptualization and treatment plan, and details of the course of treatment including specific interventions and mechanisms of change. For program abstracts, review the current program or policy, stating the necessity for change.
• Results. For research (basic & applied, meta-analysis & systematic review) abstracts, present your results in a logical sequence. For clinical case study abstracts, summarize qualitative and/or quantitative changes and note the clinical significance of the outcomes. For program abstracts, present results and impact of programmatic changes or policy implementation.
• Conclusions and Implications. Emphasize new and important aspects of the research study, case eport, or program/policy implementation and the conclusions drawn from them. Describe how findings are relevant to the science and practice of AYA oncology, the need for future research or
  clinical investigation. Special emphasis will be given to implications for advancing diversity, equity, and inclusion or reducing health disparities in AYA oncology.

Word Limit for all Submission Types:

• The Background/Introduction, Aims/Objectives Methodology, Results, Discussion/Conclusions must be 300 words or fewer. References, co- authors, keywords, and learning objectives are not counted in the word limit.

 Breakout Session Submission Guidelines:

• The session chair/convener must submit session title, overall description, and each presenter’s name/email
  using the online submission system. The system will contact the proposed speakers to submit individual
  abstracts online, linking the speaker abstracts to the session title. For more information, see the instruction
  sheet. Breakout session abstracts will be reviewed as a group and will be accepted or rejected as a group. If
  your breakout session is not accepted, you may resubmit your individual abstract as a poster or oral
  presentation. The breakout session chair is responsible for communicating conference information to
  individual speakers. It is preferred that breakout session speakers do not represent the same institution.
  Breakout session abstracts that address the conference theme and objectives will be preferred.
  Should you have any questions, please contact the Executive Office at [email protected]
  or call (615) 324-2365.